TETROFOSMIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H40O4P2
Molecular Weight	382.4553
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TETROFOSMIN

Structure Search

SMILES

CCOCCP(CCOCC)CCP(CCOCC)CCOCC

InChI

InChIKey=QCWJONLQSHEGEJ-UHFFFAOYSA-N

InChI=1S/C18H40O4P2/c1-5-19-9-13-23(14-10-20-6-2)17-18-24(15-11-21-7-3)16-12-22-8-4/h5-18H2,1-4H3

HIDE SMILES / InChI

Molecular Formula	C18H40O4P2
Molecular Weight	382.4553
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:30:13 UTC 2023` Edited by `admin` on `Fri Dec 15 15:30:13 UTC 2023`
Record UNII	3J0KPB596Q
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TETROFOSMIN

Official Name

English

TETROFOSMIN [USAN]

Common Name

English

TETROFOSMIN [JAN]

Common Name

English

P-53

Code

English

tetrofosmin [INN]

Common Name

English

Tetrofosmin [WHO-DD]

Common Name

English

3,12-DIOXA-6,9-DIPHOSPHATETRADECANE, 6,9-BIS(2-ETHOXYETHYL)-

Systematic Name

English

Ethylenebis[bis(2-ethoxyethyl)phosphine]

Systematic Name

English

TETROFOSMIN [II]

Common Name

English

TETROFOSMIN [MI]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C1937

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

EU-Orphan Drug

EU/3/16/1764

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

Code System Code Type Description

NCI_THESAURUS

C66594

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

USAN

EE-5

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

INN

6886

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

FDA UNII

3J0KPB596Q

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

SMS_ID

100000082740

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

DRUG CENTRAL

3592

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

RXCUI

1311569

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

RxNorm

EVMPD

SUB10950MIG

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

DRUG BANK

DB11180

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

CAS

127502-06-1

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

MERCK INDEX

m10665

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

Merck Index

DAILYMED

3J0KPB596Q

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

EPA CompTox

DTXSID70155591

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

ChEMBL

CHEMBL1615784

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

PUBCHEM

4274

Created by admin on Fri Dec 15 15:30:13 UTC 2023 , Edited by admin on Fri Dec 15 15:30:13 UTC 2023

PRIMARY

Related Record Type Details


					GHC34M30BG

2,2-BIS(HYDROXYMETHYL)-1-AZABICYCLO(2,2,2,)OCTAN-3-ONE

INHIBITOR -> TARGET

Interaction Type:

BINDING


					MU4ZZ5TGB7

INHIBITOR -> TARGET

Interaction Type:

BINDING

Amount:


					BIQ6AID2B7

TENOVIN-1

INHIBITOR -> TARGET

Interaction Type:

BINDING


					ID6YB4W3V8

INHIBITOR -> TARGET

Interaction Type:

ANTAGONIST

Qualification:

IC50


					42FOP1YX93

TECHNETIUM TC-99M TETROFOSMIN

LABELED -> NON-LABELED


					07LAI4EU2Y

RITA

INHIBITOR -> TARGET

Interaction Type:

BINDING


					8570LZ3RCA

INHIBITOR -> TARGET

Comments:

MI-773 (SAR405838) is an orally available MDM2 antagonist with Ki of 0.88 nM. Phase 1

Interaction Type:

ANTAGONIST

Qualification:

IC50

Amount:

Related Record Type Details


					3J0KPB596Q

ACTIVE MOIETY